Global Structural Heart Imaging Market Report and Forecast 2017-2032
The global structural heart imaging market size was valued at USD 17.4 billion in 2023. It is expected to grow at a compound annual growth rate (CAGR) of 10.11% reaching a value of USD 41.3 billion by 2032. The major factors driving the growth of the global structural heart imaging market are the increasing prevalence of structural heart diseases, the rising adoption of minimally invasive therapies, the technological advancements in imaging modalities, and the growing geriatric population.Structural heart imaging refers to the use of various imaging modalities, such as echocardiography, computed tomography (CT), magnetic resonance imaging (MRI), and nuclear imaging, to diagnose and monitor the structural abnormalities of the heart, such as valvular diseases, congenital defects, and cardiomyopathies. Structural heart imaging plays a vital role in the planning and guidance of minimally invasive procedures, such as transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair (TMVR), and left atrial appendage closure (LAAC).
According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death globally, accounting for 17.9 million deaths in 2019. Among CVDs, structural heart diseases, such as aortic stenosis, mitral regurgitation, and atrial septal defect, affect millions of people worldwide and pose a significant burden on the healthcare system. The demand for structural heart imaging is expected to increase as more patients seek early diagnosis and treatment of these conditions.
However, the global structural heart imaging market also faces some challenges, such as the high cost and complexity of imaging equipment, the lack of skilled and trained professionals, the stringent regulatory environment, and the reimbursement issues in some regions. These factors may hamper market growth to some extent during the forecast period.
Global Structural Heart Imaging Market Drivers and Constraints
Market Drivers
- The increasing prevalence of structural heart diseases, such as aortic stenosis, mitral regurgitation, and atrial septal defect, which require early diagnosis and treatment to prevent complications and mortality.
- The rising adoption of minimally invasive therapies, such as transcatheter aortic valve replacement (TAVR), transcatheter mitral valve repair (TMVR), and left atrial appendage closure (LAAC), which offer less morbidity, shorter hospital stay, and better outcomes than open-heart surgery.
- The technological advancements in imaging modalities, such as echocardiography, computed tomography (CT), magnetic resonance imaging (MRI), and nuclear imaging, which enable high-resolution, three-dimensional, and real-time visualization of the cardiac structures and function.
- The growing geriatric population, which is more prone to develop structural heart diseases due to aging-related changes in the cardiac valves and tissues.
Market Constraints
- The high cost and complexity of imaging equipment, which may limit the accessibility and affordability of structural heart imaging, especially in low- and middle-income countries.
- The lack of skilled and trained professionals, such as cardiologists, radiologists, and sonographers, who can perform and interpret structural heart imaging accurately and efficiently.
- The stringent regulatory environment, which may pose challenges for the approval and market entry of new and innovative imaging devices and software.
- The reimbursement issues in some regions may affect the adoption and utilization of structural heart imaging, especially for novel and expensive procedures.
Global Structural Heart Imaging Market Trends and Developments
The global structural heart imaging market has been experiencing several key trends in recent years, driven by advancements in technology, increasing prevalence of structural heart diseases, and a growing emphasis on early and accurate diagnosis. Here are some of the latest market trends:Advancements in Imaging Technologies: There has been significant progress in imaging technologies such as echocardiography, computed tomography (CT), and magnetic resonance imaging (MRI). 3D imaging, for instance, provides detailed views of heart structures, facilitating better diagnosis and treatment planning.
- Integration of Artificial Intelligence (AI): AI and machine learning are increasingly being integrated into structural heart imaging systems. AI algorithms can assist in automating image analysis, improving accuracy, and reducing diagnosis time.
- Minimally Invasive Procedures: The rise in minimally invasive procedures for treating structural heart diseases, such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR), is driving the demand for precise imaging techniques to guide these procedures.
- Portable and Handheld Devices: There is a growing trend towards the development of portable and handheld imaging devices. These devices are especially useful in remote areas and for point-of-care diagnostics.
- Focus on Personalized Medicine: Personalized treatment plans based on detailed structural heart imaging are becoming more common. This approach ensures that patients receive tailored therapies that are most likely to be effective for their specific condition.
- Collaboration between Industry and Healthcare Providers: Partnerships between imaging technology companies and healthcare providers are increasing, aiming to develop innovative solutions and improve patient outcomes.
- Expansion in Emerging Markets: The structural heart imaging market is expanding in emerging economies due to increasing awareness of heart diseases, improving healthcare infrastructure, and rising healthcare expenditures.
- Regulatory Approvals for Advanced Systems: Regulatory approvals for new and advanced imaging systems are accelerating their adoption in clinical practice. These systems offer enhanced resolution and clearer images for better diagnosis and treatment planning.
Global Structural Heart Imaging Market Segmentation
Market Breakup by Imaging Modality
- Echocardiography (2D and 3D)
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- Angiography (including Transesophageal Echocardiography)
- Nuclear Imaging
- Others
Market Breakup by Imaging Application
- Valvular Heart Disease
- Congenital Heart Disease
- Cardiomyopathy
- Others
Market Breakup by Imaging Technology
- 2D Imaging
- 3D Imaging
- 4D Imaging
- Doppler Imaging
- Contrast Imaging
Market Breakup by Imaging Test Type
- Stress Testing
- Transthoracic Echocardiogram (TTE)
- Transesophageal Echocardiogram (TEE)
- Cardiac Catheterization
- Others
Market Breakup by Imaging End User
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical Centers
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Structural Heart Imaging Market Competitive Landscape
The global structural heart imaging market is highly competitive and fragmented, with the presence of several large and small players. The key players in the market are focusing on product innovation, strategic partnerships, mergers and acquisitions, and geographic expansion to gain a competitive edge and increase their market share.Some of the key players and recent developments in the market are General Electric Company (GE Healthcare), Siemens Healthineers AG, Koninklijke Philips N.V., Canon Medical Systems Corporation, Hitachi, Ltd., Shimadzu Corporation, Esaote S.p.A., FUJIFILM Holdings Corporation, Samsung Medison Co., Ltd., Carestream Health, Inc., Toshiba Corporation (Canon Medical Systems), ESAOTE SPA, Mindray Medical International Limited, Pie Medical Imaging, and 3mensio Medical Imaging B.V. (A part of Pie Medical Imaging).
This product will be delivered within 5-7 business days.
Table of Contents
1 Preface1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Structural Heart Imaging Market Overview
3.1 Global Structural Heart Imaging Market Historical Value (2017-2023)
3.2 Global Structural Heart Imaging Market Forecast Value (2024-2032)
4 Global Structural Heart Imaging Market Landscape*
4.1 Global Structural Heart Imaging: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Structural Heart Imaging: Product Landscape
4.2.1 Analysis by Imaging Modality
4.2.2 Analysis by Application
5 Global Structural Heart Imaging Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Structural Heart Imaging Market Segmentation (2017-2032)
6.1 Global Structural Heart Imaging Market (2017-2032) by Imaging Modality
6.1.1 Market Overview
6.1.2 Echocardiography (2D and 3D)
6.1.3 Magnetic Resonance Imaging (MRI)
6.1.4 Computed Tomography (CT)
6.1.5 Angiography (including Transesophageal Echocardiography)
6.1.6 Nuclear Imaging
6.1.7 Others
6.2 Global Structural Heart Imaging Market (2017-2032) by Application
6.2.1 Market Overview
6.2.2 Valvular Heart Disease
6.2.3 Congenital Heart Disease
6.2.4 Cardiomyopathy
6.2.5 Others
6.3 Global Structural Heart Imaging Market (2017-2032) by Technology
6.3.1 Market Overview
6.3.2 2D Imaging
6.3.3 3D Imaging
6.3.4 4D Imaging
6.3.5 Doppler Imaging
6.3.6 Contrast Imaging
6.4 Global Structural Heart Imaging Market (2017-2032) by Test Type
6.4.1 Market Overview
6.4.2 Stress Testing
6.4.3 Transthoracic Echocardiogram (TTE)
6.4.4 Transesophageal Echocardiogram (TEE)
6.4.5 Cardiac Catheterization
6.4.6 Others
6.5 Global Structural Heart Imaging Market (2017-2032) by End User
6.5.1 Hospitals
6.5.2 Diagnostic Imaging Centers
6.5.3 Ambulatory Surgical Centers
6.5.4 Others
6.6 Global Structural Heart Imaging Market (2017-2032) by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Structural Heart Imaging Market (2017-2032)
7.1 North America Structural Heart Imaging Market (2017-2032) by Imaging Modality
7.1.1 Market Overview
7.1.2 Echocardiography (2D and 3D)
7.1.3 Magnetic Resonance Imaging (MRI)
7.1.4 Computed Tomography (CT)
7.1.5 Angiography (including Transesophageal Echocardiography)
7.1.6 Nuclear Imaging
7.1.7 Others
7.2 North America Structural Heart Imaging Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Valvular Heart Disease
7.2.3 Congenital Heart Disease
7.2.4 Cardiomyopathy
7.2.5 Others
7.3 North America Structural Heart Imaging Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Structural Heart Imaging Market (2017-2032)
8.1 Europe Structural Heart Imaging Market (2017-2032) by Imaging Modality
8.1.1 Market Overview
8.1.2 Echocardiography (2D and 3D)
8.1.3 Magnetic Resonance Imaging (MRI)
8.1.4 Computed Tomography (CT)
8.1.5 Angiography (including Transesophageal Echocardiography)
8.1.6 Nuclear Imaging
8.1.7 Others
8.2 Europe Structural Heart Imaging Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Valvular Heart Disease
8.2.3 Congenital Heart Disease
8.2.4 Cardiomyopathy
8.2.5 Others
8.3 Europe Structural Heart Imaging Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Structural Heart Imaging Market (2017-2032)
9.1 Asia Pacific Structural Heart Imaging Market (2017-2032) by Imaging Modality
9.1.1 Market Overview
9.1.2 Echocardiography (2D and 3D)
9.1.3 Magnetic Resonance Imaging (MRI)
9.1.4 Computed Tomography (CT)
9.1.5 Angiography (including Transesophageal Echocardiography)
9.1.6 Nuclear Imaging
9.1.7 Others
9.2 Asia Pacific Structural Heart Imaging Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Valvular Heart Disease
9.2.3 Congenital Heart Disease
9.2.4 Cardiomyopathy
9.2.5 Others
9.3 Asia Pacific Structural Heart Imaging Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Structural Heart Imaging Market (2017-2032)
10.1 Latin America Structural Heart Imaging Market (2017-2032) by Imaging Modality
10.1.1 Market Overview
10.1.2 Echocardiography (2D and 3D)
10.1.3 Magnetic Resonance Imaging (MRI)
10.1.4 Computed Tomography (CT)
10.1.5 Angiography (including Transesophageal Echocardiography)
10.1.6 Nuclear Imaging
10.1.7 Others
10.2 Latin America Structural Heart Imaging Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Valvular Heart Disease
10.2.3 Congenital Heart Disease
10.2.4 Cardiomyopathy
10.2.5 Others
10.3 Latin America Structural Heart Imaging Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Structural Heart Imaging Market (2017-2032)
11.1 Middle East and Africa Structural Heart Imaging Market (2017-2032) by Imaging Modality
11.1.1 Market Overview
11.1.2 Echocardiography (2D and 3D)
11.1.3 Magnetic Resonance Imaging (MRI)
11.1.4 Computed Tomography (CT)
11.1.5 Angiography (including Transesophageal Echocardiography)
11.1.6 Nuclear Imaging
11.1.7 Others
11.2 Middle East and Africa Structural Heart Imaging Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Valvular Heart Disease
11.2.3 Congenital Heart Disease
11.2.4 Cardiomyopathy
11.2.5 Others
11.3 Middle East and Africa Structural Heart Imaging Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 General Electric Company (GE Healthcare)
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Siemens Healthineers AG
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Koninklijke Philips N.V.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Canon Medical Systems Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Hitachi, Ltd.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Shimadzu Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Esaote S.p.A.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 FUJIFILM Holdings Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Samsung Medison Co., Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Carestream Health, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Toshiba Corporation (Canon Medical Systems)
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 ESAOTE SPA
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Mindray Medical International Limited
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Pie Medical Imaging
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 3mensio Medical Imaging B.V. (A part of Pie Medical Imaging)
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
List not exhaustive
18 Global Structural Heart Imaging Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The research team strives to make this section as comprehensive as possible.
Companies Mentioned
- General Electric Company (GE Healthcare)
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- Canon Medical Systems Corporation
- Hitachi, Ltd.
- Shimadzu Corporation
- Esaote S.p.A.
- FUJIFILM Holdings Corporation
- Samsung Medison Co., Ltd.
- Carestream Health, Inc.
- Toshiba Corporation (Canon Medical Systems)
- ESAOTE SPA
- Mindray Medical International Limited
- Pie Medical Imaging
- 3mensio Medical Imaging B.V. (A part of Pie Medical Imaging).
Methodology
LOADING...
